Opportunity Information: Apply for CDC RFA IP16 1608PPHF16
Apply for CDC RFA IP16 1608PPHF16
- The HHS-CDC-NCIRD in the health sector is offering a public funding opportunity titled "PPHF 2016: Increasing HPV Vaccine Coverage by Strengthening Adolescent AFIX Activities, Financed in Part by 2016 Prevention and Public Health Funds" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.733.
- This funding opportunity was created on May 02, 2016 and posted on May 02, 2016.
- Applicants must submit their applications by Jun 04, 2016. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $500,000.00 in funding.
- The number of recipients for this funding is limited to 20 candidate(s).
- Eligible applicants include: State governments, City or township governments, Special district governments.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "PPHF 2016: Increasing HPV Vaccine Coverage by Strengthening Adolescent AFIX Activities, Financed in Part by 2016 Prevention and Public Health Funds" is a CDC-funded cooperative agreement designed to raise HPV vaccination rates among adolescents by expanding and strengthening the AFIX approach. AFIX, which stands for Assessment, Feedback, Incentives, and eXchange, is presented as a practical, research-informed quality improvement method that works directly at the immunization provider level. The core idea is that improving how clinics and health systems deliver vaccines, track patients, and follow up on missed opportunities can meaningfully increase vaccination coverage, especially for HPV, where adolescent uptake has historically lagged behind public health goals.
A central feature of AFIX is the in-person, face-to-face visit between trained AFIX staff and the provider’s clinical and administrative staff who influence immunization workflows. The funding notice emphasizes that this interaction is not just a data review; it is meant to be an active quality improvement intervention. During these sessions, AFIX staff assess a practice’s immunization performance, share targeted feedback, provide education and outreach, and work with the practice to build agreement around specific improvements. The expectation is that providers leave the visit with a clearer plan for strengthening immunization service delivery using concrete QI methods, rather than simply receiving a report card.
The rationale for investing in AFIX is grounded in evidence that assessment and feedback, especially when paired with other supports like incentives and peer exchange, can increase vaccination rates across many settings. The opportunity cites the Task Force on Community Preventive Services, which reaffirmed in 2008 that assessment and feedback are recommended based on strong evidence of effectiveness. It also points to CDC’s Advisory Committee on Immunization Practices (ACIP), which references this evidence in its general recommendations. In other words, the grant frames AFIX as a proven strategy that has enough research backing to justify scaling it up, particularly for adolescent vaccines like HPV.
The program’s focus is specifically on adolescent HPV vaccine coverage, described as "unacceptably low," and on the fact that adolescent-focused AFIX has been underused. The CDC highlights that this funding is meant to improve both the volume and the quality of AFIX visits. That means not only conducting more visits, but also ensuring those visits are performed according to the AFIX Policies and Procedures Guide and are strong enough to change provider behavior and clinic systems. The notice also references early or preliminary results from prior PPHF-funded HPV vaccination efforts and other recent AFIX activities, suggesting that HPV vaccination coverage can improve when AFIX is applied intentionally to adolescent vaccination practices.
Operationally, awardees are expected to target provider sites with low adolescent immunization coverage, prioritizing places where improvements could have the biggest effect. This can include large health networks or individual high-volume clinics that serve large adolescent populations, since reaching more patients per site can maximize impact. Recipients are encouraged to expand existing adolescent AFIX strategies already in use or to introduce new adolescent-focused approaches, as long as they align with AFIX standards. A major deliverable is increasing the number of adolescent AFIX visits that are actually implemented and completed, not just planned.
Accountability and evaluation are built into the grant through required reporting and data submission. The CDC expects recipients to provide information needed to evaluate both how AFIX is being carried out (process measures) and whether it is improving vaccination coverage (outcome measures). The notice mentions progress reports, online data reporting, and regular check-in calls as mechanisms for monitoring and supporting implementation. This evaluation requirement is framed as part of improving the overall AFIX strategy over time, not just documenting activity.
In terms of grant mechanics, the opportunity is listed as a discretionary award using a cooperative agreement structure, which typically means CDC involvement is more hands-on than in a standard grant. It is administered by HHS/CDC through the National Center for Immunization and Respiratory Diseases (NCIRD). The eligible applicants are governmental entities, specifically state governments, city or township governments, and special district governments. The funding opportunity number is CDC RFA IP16-1608PPHF16, and it is associated with CFDA 93.733. The posting and creation date are May 2, 2016, with an application closing date of June 4, 2016. The award ceiling is listed at $500,000, with an expected 20 awards, indicating an effort to support multiple jurisdictions in scaling up adolescent AFIX work to move closer to targets such as Healthy People 2020 and relevant HEDIS immunization performance measures.
FAQs: PPHF 2016 Increasing HPV Vaccine Coverage by Strengthening Adolescent AFIX Activities
What is the title of this grant opportunity?
The opportunity is titled "PPHF 2016: Increasing HPV Vaccine Coverage by Strengthening Adolescent AFIX Activities, Financed in Part by 2016 Prevention and Public Health Funds."
Which federal agency is funding and administering this opportunity?
This is a CDC-funded cooperative agreement administered by HHS/CDC through the National Center for Immunization and Respiratory Diseases (NCIRD).
What is the main purpose of the funding?
The purpose is to raise HPV vaccination rates among adolescents by expanding and strengthening adolescent-focused AFIX activities, with an emphasis on improving both the number of AFIX visits conducted and the quality of those visits.
What does AFIX stand for?
AFIX stands for Assessment, Feedback, Incentives, and eXchange.
What is AFIX in practical terms?
AFIX is described as a practical, research-informed quality improvement method that works directly at the immunization provider level to improve vaccine delivery systems, patient tracking, and follow-up on missed opportunities.
What is the core strategy AFIX uses to improve vaccination coverage?
A central feature is an in-person, face-to-face visit between trained AFIX staff and the provider site's clinical and administrative staff who influence immunization workflows. The visit is intended to function as an active quality improvement intervention, not just a data review.
What typically happens during an AFIX visit under this program?
During the session, AFIX staff assess a practice's immunization performance, provide targeted feedback, offer education and outreach, and work with the practice to build agreement around specific improvements so the provider leaves with a concrete plan to strengthen immunization service delivery using quality improvement methods.
Is the program focused on HPV only, or adolescent vaccination more broadly?
The notice emphasizes adolescent HPV vaccine coverage as the specific focus, describing it as "unacceptably low," while framing AFIX as a provider-level approach that improves vaccination practices and systems.
Why is CDC investing in AFIX for this opportunity?
The opportunity frames AFIX as a proven approach supported by evidence that assessment and feedback can increase vaccination rates. It cites the Task Force on Community Preventive Services, which reaffirmed in 2008 that assessment and feedback are recommended based on strong evidence, and notes that ACIP references this evidence in its general recommendations.
What does the opportunity mean by improving the "volume" of AFIX visits?
It means increasing the number of adolescent AFIX visits that are implemented and completed, not just planned.
What does the opportunity mean by improving the "quality" of AFIX visits?
It means ensuring AFIX visits are conducted according to the AFIX Policies and Procedures Guide and are strong enough as quality improvement interventions to change provider behavior and clinic or health system processes.
Which provider sites are awardees expected to prioritize?
Awardees are expected to target provider sites with low adolescent immunization coverage and prioritize locations where improvement could have the biggest effect, including large health networks or individual high-volume clinics serving large adolescent populations.
Can recipients build on existing AFIX efforts, or must they create new strategies?
Recipients are encouraged to expand existing adolescent AFIX strategies already in use or introduce new adolescent-focused approaches, as long as they align with AFIX standards.
What kinds of outcomes is the program trying to influence?
The program aims to increase HPV vaccination coverage among adolescents and to move closer to benchmarks such as Healthy People 2020 targets and related HEDIS immunization performance measures.
What reporting or evaluation expectations are included?
Accountability is built in through required reporting and data submission. Recipients are expected to provide information needed to evaluate both process measures (how AFIX is carried out) and outcome measures (whether vaccination coverage is improving). The notice mentions progress reports, online data reporting, and regular check-in calls.
How does the CDC describe the purpose of evaluation in this program?
Evaluation is framed as a way to monitor and support implementation and to improve the overall AFIX strategy over time, not only to document activity.
What type of award mechanism is this?
This is a discretionary award using a cooperative agreement structure, which generally indicates more hands-on CDC involvement than a standard grant.
Who is eligible to apply?
Eligible applicants are governmental entities: state governments, city or township governments, and special district governments.
What is the funding opportunity number?
The funding opportunity number is CDC RFA IP16-1608PPHF16.
What is the CFDA number associated with this opportunity?
The opportunity is associated with CFDA 93.733.
What are the key dates listed for this opportunity?
The posting and creation date is May 2, 2016, and the application closing date is June 4, 2016.
What is the maximum award amount (award ceiling)?
The award ceiling is listed as $500,000.
How many awards are expected?
The notice lists an expected 20 awards.
What does "Financed in Part by 2016 Prevention and Public Health Funds" indicate?
It indicates that the project is financed in part by 2016 Prevention and Public Health Funds (PPHF), as stated in the opportunity title.
What is the role of provider workflow improvement in increasing HPV coverage?
The opportunity emphasizes that improving clinic and health system practices around vaccine delivery, patient tracking, and follow-up on missed opportunities can meaningfully increase vaccination coverage, particularly for HPV where adolescent uptake has lagged behind public health goals.
Does the notice mention prior results or background experiences that informed this funding?
Yes. It references early or preliminary results from prior PPHF-funded HPV vaccination efforts and other recent AFIX activities, suggesting HPV vaccination coverage can improve when AFIX is applied intentionally to adolescent vaccination practices.
Browse more opportunities from the same category: Health
Next opportunity: Medical Professionals Recruitment and Continuing Education Program
Previous opportunity: Geophysical Sub-surface Surveys
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA IP16 1608PPHF16
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA IP16 1608PPHF16) also looked into and applied for these:
| Funding Opportunity |
|---|
| Medical Professionals Recruitment and Continuing Education Program Apply for HHS 2016 IHS HPR 0001 Funding Number: HHS 2016 IHS HPR 0001 Agency: HHS-IHS Category: Health Funding Amount: $105,000 |
| Improving Access to Care: Using Community Health Workers to Improve Linkage and Retention in HIV Care Apply for HRSA 16 185 Funding Number: HRSA 16 185 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Community Health Projects Related to Contamination at Brownfield/Land Reuse Sites Apply for CDC RFA TS16 1602 Funding Number: CDC RFA TS16 1602 Agency: HHS-CDC-ATSDR Category: Health Funding Amount: $150,000 |
| 2016 Senior Companion Program (SCP) Indian Tribes, Native Hawaiians, and Pacific Islanders Competition Apply for CNCS 05 04 2016 SCP Funding Number: CNCS 05 04 2016 SCP Agency: CNCS Category: Health Funding Amount: Case Dependent |
| Aging Research to Address Health Disparities (Admin Supplement) Apply for PA 16 225 Funding Number: PA 16 225 Agency: HHS-NIH11 Category: Health Funding Amount: $45,500 |
| AHRQ Mentored Research Scientist Research Career Development Award (K01) Apply for PA 16 223 Funding Number: PA 16 223 Agency: HHS-AHRQ Category: Health Funding Amount: Case Dependent |
| Improving Physical Infrastructure to Enhance Animal Model Research: Revisions of Research Project Grants (R01) Apply for RFA OD 16 008 Funding Number: RFA OD 16 008 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Leadership Training for People of Color Living with HIV Apply for HRSA 16 186 Funding Number: HRSA 16 186 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Clinical Sequencing Evidence-Generating Research (CSER2) - Coordinating Center (U24) Apply for RFA HG 16 012 Funding Number: RFA HG 16 012 Agency: HHS-NIH11 Category: Health Funding Amount: $645,000 |
| Non-healing Ulcerative Wounds in Aging (R21) Apply for PA 16 231 Funding Number: PA 16 231 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Comprehensive Alcohol Research Centers (P60) Apply for RFA AA 17 002 Funding Number: RFA AA 17 002 Agency: HHS-NIH11 Category: Health Funding Amount: $1,250,000 |
| Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R21) Apply for PA 16 244 Funding Number: PA 16 244 Agency: HHS-NIH11 Category: Health Funding Amount: $200,000 |
| Mechanisms Mediating Osteoarthritis in Aging (R21) Apply for PA 16 240 Funding Number: PA 16 240 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Behavioral Health Workforce Education and Training (BHWET) for Paraprofessionals and Professionals Apply for HRSA 16 193 Funding Number: HRSA 16 193 Agency: HHS-HRSA Category: Health Funding Amount: Case Dependent |
| Limited Competition: NIGMS Mature Synchrotron Resources for Structural Biology (P30) Apply for PAR 16 247 Funding Number: PAR 16 247 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE)(P20) Apply for PAR 16 241 Funding Number: PAR 16 241 Agency: HHS-NIH11 Category: Health Funding Amount: $1,500,000 |
| Mechanisms Mediating Osteoarthritis in Aging (R01) Apply for PA 16 239 Funding Number: PA 16 239 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
| Impact of Aging in Human Cell Models of Alzheimer's Disease (R01) Apply for RFA AG 17 009 Funding Number: RFA AG 17 009 Agency: HHS-NIH11 Category: Health Funding Amount: $250,000 |
| Specialized Alcohol Research Centers (P50) Apply for RFA AA 17 001 Funding Number: RFA AA 17 001 Agency: HHS-NIH11 Category: Health Funding Amount: $1,150,000 |
| Novel Approaches to Understanding, Preventing and Treating Lyme Disease and Tick-borne Coinfections (R01) Apply for PA 16 243 Funding Number: PA 16 243 Agency: HHS-NIH11 Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA IP16 1608PPHF16", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
